Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
ZNTL
#3079
Zentalis Pharmaceuticals, Inc. Common Stock
2.3
9
-0.42%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-0.42%
Mudança mensal
-18.98%
Mudança em 6 meses
+32.78%
Mudança anual
+17.73%
Fechamento anterior
2.4
0
Open
2.3
9
Bid
Ask
Low
2.3
9
High
2.3
9
Volume
70
Mercados
Ações
Cuidados de saúde
ZNTL
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
41.04 M
45.56 M
59.42 M
70.96 M
71.81 M
—
Valuation ratios
Enterprise value
2.1 B
3.77 B
1.18 B
1.11 B
183.69 M
372.27 M
Price to earnings ratio
—
-22.6
-4.61
-3.58
-1.3
-3.04
Price to sales ratio
—
239.22 K
19.49 K
1 162.1
3.19
14.47
Price to cash flow ratio
—
-23.29
-6.67
-5.03
-1.26
-3.36
Price to book ratio
—
3.31
0.67
2.39
0.64
0.88
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.32
0.35
0.44
0.53
0.39
0.35
Return on equity %
0.35
0.44
0.55
0.67
0.49
0.45
Return on invested capital %
222.76
444.81
540.5
477.87
396.7
875.44
Gross margin %
—
100
100
100
100
—
Operating margin %
—
1.44 M
405.87 K
33.28 K
283.57
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
1.06 M
422.87 K
32.47 K
245.96
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
12.07
7.98
7.98
7.16
7.32
30
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
0
0
0.14
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
3.61
3.1
3.18
2.4
1.87
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
5.49
6.11
2.16
6.05
16.53
Net current asset value per share
—
8.22
8.55
7.59
5.43
18.54
Tangible book value per share
—
25.29
30.75
6.63
4.74
16.18
Working capital per share
—
7.19
7.48
6.53
4.69
16.05
Book value per share
—
25.38
30.82
6.69
4.74
16.18
Notícias
Zentalis Pharma CEO Eastland sells $21k in shares
Zentalis Pharma CMO Bruns sells $7998 in stock
Zentalis Pharmaceuticals: PAO vende azioni per 7.800 dollari
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Obiettivo di prezzo di Zentalis Pharmaceuticals ridotto a $2 da Leerink Partners
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
H.C. Wainwright maintains buy rating on Zentalis stock after ASCO update
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress